ArticleDiscover oncology2022

SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma.

Huayi Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.